Accelerated FDA approval of the first-in-class CELMoD agent iberdomide (Zenbexus) offers a new oral option for adults with relapsed or refractory multiple myeloma.

A Prescription Drug User Fee Act target date of February 12, 2027 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...

HealthDay News — A new executive order calls for American children to be routinely immunized against 11 diseases instead of the 17 now recommended by federal health officials. President Donald Trump ...

HealthDay News — A multistate outbreak of Salmonella infections has been linked to fresh jalapeño peppers imported from Sinaloa, Mexico, according to federal health officials.

FDA acceptance of the new drug application for lonafarnib marks a key milestone toward an oral treatment option for chronic hepatitis D.

The 4C meningococcal B (MenB) vaccine confers modest protection against gonorrhea among adolescents, according to a study published online August 4 in Open Foru ...

Thirteen conditional recommendations developed, including in relation to guiding therapy during exacerbations.

Single-dose DT120 ODT achieved significant, sustained reductions in HAM-A anxiety scores vs placebo at week 12, with clinical efficacy observed as early as day 2. Positive topline data were announced ...

Prespecified primary analyses showed significant improvement over placebo in patients aged 71 and older and those with a baseline 6MWD below 333 meters.

Casgevy (exagamglogene autotemcel) Autologous genome-edited hematopoietic stem cell-based gene therapy Treatment of patients aged 2 years and older with sickle cell disease with recurrent ...

The recalled product is labeled Tyenne (tocilizumab-aazg) Injection 400mg/20mL (20mg/mL)20mL vials; Lot# 16UI07; NDC# 65219-594-20; Expiration Date of 08/2028. One lot of Tyenne ® (tocilizumab-aazg) ...